Upgrade to SI Premium - Free Trial

BMO Capital Reiterates Market Perform Rating on Merck (MRK) Following Earnings

February 3, 2022 7:46 AM
BMO Capital analyst Evan David Seigerman reiterated a Market Perform rating and $87.00 price target on Merck (NYSE: MRK), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Trader Talk

Next Articles